Mengmeng Li, Kaili Yin, Liang Chen, Jiazhen Chang, Na Hao
{"title":"Gene Analysis of Four Families with Severe Peripartum Cardiomyopathy Reveals Known Gene Mutations and Supports the Recent Call for Screening.","authors":"Mengmeng Li, Kaili Yin, Liang Chen, Jiazhen Chang, Na Hao","doi":"10.31083/j.rcm2511399","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Peripartum cardiomyopathy (PPCM) is a rare disease that causes maternal morbidity and mortality worldwide. However, the etiology of PPCM is still unclear, and the rate of recovery varies between patients. Understanding the genetic factors underpinning PPCM may provide new insights into its pathogenesis.</p><p><strong>Methods: </strong>This genetic study screened six patients with severe PPCM and their family members using a panel of 204 genes associated with inherited cardiomyopathy.</p><p><strong>Results: </strong>The six probands progressed to severe cardiac dysfunction during follow-up, with a low left ventricular ejection fraction of <30% and a significant increase in left ventricular end-diastolic diameter. Genetic analysis showed that four of the six probands had pathogenic mutations. No specific mutation was identified in the other two probands. Further screening of the probands' families identified that eight family members shared the same mutation with their probands. The total positive genetic mutation rate was 46% (12/26). Among those with genetic mutations, women who had pregnancies showed symptoms of heart disease.</p><p><strong>Conclusions: </strong>For PPCM patients with a genetic predisposition, pregnancy may exert pathogenic effects in terms of disease initiation and progression. Patients with PPCM with a first-degree relative diagnosed with inherited cardiomyopathy may benefit from genetic counselling.</p>","PeriodicalId":20989,"journal":{"name":"Reviews in cardiovascular medicine","volume":"25 11","pages":"399"},"PeriodicalIF":1.9000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11607517/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in cardiovascular medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31083/j.rcm2511399","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Peripartum cardiomyopathy (PPCM) is a rare disease that causes maternal morbidity and mortality worldwide. However, the etiology of PPCM is still unclear, and the rate of recovery varies between patients. Understanding the genetic factors underpinning PPCM may provide new insights into its pathogenesis.
Methods: This genetic study screened six patients with severe PPCM and their family members using a panel of 204 genes associated with inherited cardiomyopathy.
Results: The six probands progressed to severe cardiac dysfunction during follow-up, with a low left ventricular ejection fraction of <30% and a significant increase in left ventricular end-diastolic diameter. Genetic analysis showed that four of the six probands had pathogenic mutations. No specific mutation was identified in the other two probands. Further screening of the probands' families identified that eight family members shared the same mutation with their probands. The total positive genetic mutation rate was 46% (12/26). Among those with genetic mutations, women who had pregnancies showed symptoms of heart disease.
Conclusions: For PPCM patients with a genetic predisposition, pregnancy may exert pathogenic effects in terms of disease initiation and progression. Patients with PPCM with a first-degree relative diagnosed with inherited cardiomyopathy may benefit from genetic counselling.
期刊介绍:
RCM is an international, peer-reviewed, open access journal. RCM publishes research articles, review papers and short communications on cardiovascular medicine as well as research on cardiovascular disease. We aim to provide a forum for publishing papers which explore the pathogenesis and promote the progression of cardiac and vascular diseases. We also seek to establish an interdisciplinary platform, focusing on translational issues, to facilitate the advancement of research, clinical treatment and diagnostic procedures. Heart surgery, cardiovascular imaging, risk factors and various clinical cardiac & vascular research will be considered.